Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +0.46% inched 0.25% higher to $165.37 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -0.47% rising 0.18% to 4,255.15 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -0.24% falling 0.25% to 34,393.75. Johnson & Johnson closed $8.28 short of its 52-week high ($173.65), which the company achieved on January 26th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/delayed RHHVF -3.05% rose 2.24% to $388.50, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +0.79% fell 0.22% to $75.45, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE +0.69% fell 1.30% to $39.63. Trading volume (4.9 M) remained 2.3 million below its 50-day average volume of 7.2 M.